Chai Discovery
AI-powered drug discovery platform using foundation models for molecular design.
About
Chai Discovery, founded in 2024 (OpenAI-backed, incubated in OpenAI offices), builds foundation models for predicting biochemical interactions. Raised $130M Series B at $1.3B valuation (Dec 2025). Partnership with Eli Lilly for drug development. Teams look it up for Artificial Intelligence, Biotechnology, Drug Discovery.
Frequently asked
What does Chai Discovery do?
Chai Discovery is an Artificial Intelligence company that offers Platform / Partnership. Teams look it up for Biotechnology, Drug Discovery, Molecular Design. It is based in San Francisco, United States and was founded in 2023. Public records show $872M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Chai Discovery raised?
Chai Discovery has raised a total of $872M in funding. The most recent round on record is Series C.
Where is Chai Discovery headquartered?
Chai Discovery is headquartered in San Francisco, United States.
When was Chai Discovery founded?
Chai Discovery was founded in 2023.
What industry does Chai Discovery operate in?
Chai Discovery operates in Artificial Intelligence, Biotechnology, Drug Discovery, Molecular Design, Foundation Models.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.